Abstract
Introduction Public health environmental surveillance has evolved, especially during the coronavirus disease pandemic, with wastewater-based surveillance being a prominent example. As surveillance methods diversify and expand, it is essential to have a robust evaluation of surveillance systems. This electronic Delphi study will propose an evaluation framework for public health environmental surveillance, informed by the expanding practice of wastewater-based surveillance during the pandemic.
Methods The Public Health Environmental Surveillance Evaluation Framework (PHES-EF) will be developed in five steps. In Step 1, a multinational and multidisciplinary executive group will be formed to guide the framework development process. In Step 2, candidate items for Round 1 of the electronic Delphi will be generated by conducting relevant scoping reviews and consultation with the study executive group. In Step 3, an international electronic Delphi will be conducted over two rounds to develop consensus on items for the framework. In Step 4, the executive group will reconvene to finalize the evaluation framework, discuss standout items, and determine the dissemination strategies. Lastly, Step 5 will focus on disseminating the evaluation framework to all parties involved with or affected by wastewater-based surveillance using traditional and public-oriented methods.
Discussion The electronic Delphi study will provide multidisciplinary and multinational consensus for the evaluation framework for public health environmental surveillance by providing a set of minimum criteria required for their evaluation. The evaluation framework is intended to support the sustainability of environmental surveillance and improve its implementation, reliability, credibility, and value.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study has received ethical approval (20230428-01H) from the Ottawa Health Science Network Research Ethics Board (OHSN-REB). Implied consent will be obtained from all panellists prior to participating in the e-Delphi survey.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Footnotes
Data availability
Anonymous aggregate data will be made publicly available when the study is completed and published.
